» Articles » PMID: 28947346

Using the 4 Pillars™ Practice Transformation Program to Increase Adolescent Human Papillomavirus, Meningococcal, Tetanus-diphtheria-pertussis and Influenza Vaccination

Overview
Journal Vaccine
Date 2017 Sep 27
PMID 28947346
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To report the results of an intervention using the 4 Pillars™ Practice Transformation Program (4 Pillars™ Program) to increase adolescent vaccinations including human papillomavirus vaccine (HPV) and influenza vaccines, which remain underutilized in this population.

Study Design: Eleven pediatric and family medicine practices, previously control sites from a randomized controlled cluster trial, with ≥50 adolescent patients participated. The 4 Pillars™ Program was the foundation of the intervention. De-identified demographic, office visit and vaccination data were derived from electronic medical record extractions for patients whose date of birth was 4/1/1997 to 4/1/2004 (ages 11-17years at baseline). Vaccination rates for HPV, influenza, tetanus-pertussis-diphtheria (Tdap) and meningococcal (MenACWY) vaccines were determined for all eligible patients pre- and post intervention (i.e., vaccination rates on 4/1/2015 and 4/30/2016).

Results: Among 9473 patients ages 11-17years at baseline (4/1/2015), mean pre-intervention vaccination rates for HPV initiation and completion, meningococcal, Tdap and influenza vaccines were below national levels. Rates increased significantly post intervention (P<0.001) for HPV initiation which increased 17.1 percentage points (PP) from 51.4%; HPV completion increased 14.8PP from 30.7%, meningococcal vaccine uptake increased 16.6PP from 79.1%, Tdap vaccine uptake increased 14.6PP from 76.9%. Influenza vaccine uptake did not increase significantly (2.3PP from 40.1%). In the regression using generalized estimating equations, odds of vaccination were higher for younger, non-white adolescents for all vaccines; being in a smaller practice decreased the odds of Tdap vaccination but increased the odds of influenza vaccination.

Conclusion: Clinically and statistically significant improvements in HPV series initiation and completion, and meningococcal and Tdap vaccinations were observed in primary care practices implementing the 4 Pillars™ Practice Transformation Program. Clinical Trial Registry Number: NCT02165722.

Citing Articles

Barriers to Human Papillomavirus Vaccination Initiation and Completion among Adults Aged 18-26 Years in a Large Healthcare System.

Khalil L, Russo E, Venkatakrishnan K, Mazul A, Zevallos J Cancers (Basel). 2023; 15(17).

PMID: 37686521 PMC: 10487182. DOI: 10.3390/cancers15174243.


An overview of implementing an evidence based program to increase HPV vaccination in HIV community clinics.

Wells J, Klosky J, Liu Y, Gillespie T BMC Public Health. 2022; 22(1):1696.

PMID: 36071389 PMC: 9450352. DOI: 10.1186/s12889-022-14100-0.


Digital Health Interventions to Enhance Prevention in Primary Care: Scoping Review.

Willis V, Craig K, Jabbarpour Y, Scheufele E, Arriaga Y, Ajinkya M JMIR Med Inform. 2022; 10(1):e33518.

PMID: 35060909 PMC: 8817213. DOI: 10.2196/33518.


A Systematic Review of Interventions to Improve HPV Vaccination Coverage.

Mavundza E, Iwu-Jaja C, Wiyeh A, Gausi B, Abdullahi L, Halle-Ekane G Vaccines (Basel). 2021; 9(7).

PMID: 34201421 PMC: 8310215. DOI: 10.3390/vaccines9070687.


Recommending immunizations to adolescents in Turkey: a study of the knowledge, attitude, and practices of physicians.

Elitok G, Bulbul L, Altuntas S, Altuntas B, Gunindi G, Haltas M Hum Vaccin Immunother. 2020; 16(5):1132-1138.

PMID: 32040380 PMC: 7227671. DOI: 10.1080/21645515.2020.1715146.


References
1.
Jeudin P, Liveright E, Carmen M, Perkins R . Race, ethnicity, and income factors impacting human papillomavirus vaccination rates. Clin Ther. 2014; 36(1):24-37. DOI: 10.1016/j.clinthera.2013.11.001. View

2.
Perkins R, Lin M, Silliman R, Clark J, Hanchate A . Why are U.S. girls getting meningococcal but not human papilloma virus vaccines? Comparison of factors associated with human papilloma virus and meningococcal vaccination among adolescent girls 2008 to 2012. Womens Health Issues. 2015; 25(2):97-104. DOI: 10.1016/j.whi.2014.12.005. View

3.
McRee A, Brewer N, Reiter P, Gottlieb S, Smith J . The Carolina HPV immunization attitudes and beliefs scale (CHIAS): scale development and associations with intentions to vaccinate. Sex Transm Dis. 2009; 37(4):234-9. DOI: 10.1097/OLQ.0b013e3181c37e15. View

4.
Widdice L, Bernstein D, Leonard A, Marsolo K, Kahn J . Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics. 2010; 127(1):77-84. PMC: 3010090. DOI: 10.1542/peds.2010-0812. View

5.
Lin C, Nowalk M, Toback S, Ambrose C . Factors associated with in-office influenza vaccination by U.S. pediatric providers. BMC Pediatr. 2013; 13:180. PMC: 3833650. DOI: 10.1186/1471-2431-13-180. View